Malignant mixed Mullerian tumor

Search Trials
Malignant Mixed Mesodermal Tumor (MMMT) – Early Stage With Postoperative XRT/Chemotherapy
Status:
Terminated
Last Changed:
Jan 1, 1970
First Changed:
Jan 1, 1970
Disease(s):
Uterine Neoplasms
Intervention(s):
CarboplatinCisplatinPaclitaxel
A Phase I Study of Lapatinib (Tykerb) Plus Ixabepilone (Ixempra) as 2nd-line Treatment for Patients With HER-2 Overexpressed Recurrent or Persistent Endometrial Carcinoma or Carcinosarcoma
Status:
Unknown status
Last Changed:
Jan 1, 1970
First Changed:
Jan 1, 1970
Disease(s):
Recurrent Endometrial Cancer
Intervention(s):
Lapatinib and ixempra
Avastin +/- Erlotinib Consolidation Chemotherapy After Carboplatin, Paclitaxel, and Avastin (CTA) Induction Therapy for Advanced Ovarian, Fallopian Tube, Primary Peritoneal Cancer & Papillary Serous or Clear Cell Mullerian Tumors
Status:
Completed
Last Changed:
Jan 1, 1970
First Changed:
Jan 1, 1970
Disease(s):
Ovarian Cancer
Intervention(s):
bevacizumaberlotinibpaclitaxelcarboplatin
Protocol to Allow Continued Access of Ficlatuzumab to P05538 Patient
Status:
No longer available
Last Changed:
Jan 1, 1970
First Changed:
Jan 1, 1970
Disease(s):
Mullerian Mixed Tumor of Ovary
Intervention(s):
ficlatuzumab
Suitability of DCE-MRI for Detection of Vascular Changes After VBT
Status:
Unknown status
Last Changed:
Jan 1, 1970
First Changed:
Jan 1, 1970
Disease(s):
Carcinoma of the Cervix, Carcinoma or Carcinosarcoma of the Uterus
Intervention(s):
Radiotherapy

Connect. Empower. Inspire.